Literature DB >> 31914330

The adverse-effect profile of lacosamide.

Jiyuan Li1, Meizhen Sun1, Xuefeng Wang2.   

Abstract

Introduction: Lacosamide has been used in epilepsy patients in the United States, Europe and Asia since it was approved by the FDA in 2008. Many patients have benefited from this drug as a new generation of sodium channel blocker. With the worldwide use of this drug, its adverse effects have gradually emerged, especially some rare adverse events.Areas covered: The present review aims to summarize the adverse effects of lacosamide reported in the literature in recent years to promote the safe clinical application of the drug.Expert opinion: In more than 10 years of experience in drug usage, adverse reactions of lacosamide have also been gradually discovered. The review showed that lacosamide is safe and effective in antiepileptic treatment, and its common side effects are dizziness, headache, drowsiness, diplopia, and cardiovascular abnormalities. Skin rashes, hematotoxicity and heart damage, psychological symptoms and suicide risk have also been reported and emphasized.

Entities:  

Keywords:  Adverse effect; anti-epileptic drug; lacosamide; safety; sodium channel blocker

Mesh:

Substances:

Year:  2020        PMID: 31914330     DOI: 10.1080/14740338.2020.1713089

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

1.  Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.

Authors:  Makoto Shibata; Reona Hoshino; Chisato Shimizu; Masayuki Sato; Natsumi Furuta; Yoshio Ikeda
Journal:  BMC Neurol       Date:  2021-06-08       Impact factor: 2.474

2.  Chinese herbal compounds containing scorpion in the treatment of epilepsy: A protocol for systematic review and meta-analysis.

Authors:  Ping Rong; Qianfang Fu; Xilian Zhang; Xuan Liu; Jie Yang; Xin Wang; Shuai Wang; Hui Liu; Rong Ma; Lianghui Nie; Rong Ma
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

3.  Evidence for Inhibitory Perturbations on the Amplitude, Gating, and Hysteresis of A-Type Potassium Current, Produced by Lacosamide, a Functionalized Amino Acid with Anticonvulsant Properties.

Authors:  Hsin-Yen Cho; Tzu-Hsien Chuang; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 4.  Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery.

Authors:  Shuli Liang; Xing Fan; Feng Chen; Yonghong Liu; Binghui Qiu; Kai Zhang; Songtao Qi; Guojun Zhang; Jinfang Liu; Jianguo Zhang; Jun Wang; Xiu Wang; Ziyang Song; Guoming Luan; Xuejun Yang; Rongcai Jiang; Hua Zhang; Lei Wang; Yongping You; Kai Shu; Xiaojie Lu; Guoyi Gao; Bo Zhang; Jian Zhou; Hai Jin; Kaiwei Han; Yiming Li; Junji Wei; Kun Yang; Gan You; Hongming Ji; Yuwu Jiang; Yi Wang; Zhiguo Lin; Yan Li; Xuewu Liu; Jie Hu; Junming Zhu; Wenling Li; Yongxin Wang; Dezhi Kang; Hua Feng; Tinghong Liu; Xin Chen; Yawen Pan; Zhixiong Liu; Gang Li; Yunqian Li; Ming Ge; Xianming Fu; Yuping Wang; Dong Zhou; Shichuo Li; Tao Jiang; Lijun Hou; Zhen Hong
Journal:  Ther Adv Neurol Disord       Date:  2022-08-16       Impact factor: 6.430

Review 5.  Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases.

Authors:  Albert Muñoz-Vendrell; Silvia Teixidor; Jacint Sala-Padró; Sergio Campoy; Mariano Huerta-Villanueva
Journal:  Cephalalgia       Date:  2022-04-26       Impact factor: 6.075

6.  Epilepsy With Suicide: A Bibliometrics Study and Visualization Analysis via CiteSpace.

Authors:  Yi Guo; Zheng-Yan-Ran Xu; Meng-Ting Cai; Wen-Xin Gong; Chun-Hong Shen
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.